Omkar Speciality Chemicals Limited (BOM:533317)
India · Delayed Price · Currency is INR 3.600
-0.180 (-4.76%)
At close: Apr 28, 2026
BOM:533317 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Operating Revenue | 0.08 | - | 229.83 | 451.25 | 568.77 |
Other Revenue | 1.59 | 2.24 | - | - | - |
| 1.68 | 2.24 | 229.83 | 451.25 | 568.77 | |
Revenue Growth (YoY) | -25.32% | -99.02% | -49.07% | -20.66% | 33.35% |
Cost of Revenue | 0.09 | - | 167 | 276.75 | 444.3 |
Gross Profit | 1.59 | 2.24 | 62.82 | 174.5 | 124.47 |
Selling, General & Admin | 0.15 | 0.94 | 29.02 | 27.26 | 36.55 |
Other Operating Expenses | 8.39 | 5.27 | 81.27 | 66.39 | 85.21 |
Operating Expenses | 17.48 | 15.28 | 128.16 | 129.24 | 187.63 |
Operating Income | -15.89 | -13.04 | -65.34 | 45.26 | -63.16 |
Interest Expense | - | - | -60.71 | -55.02 | -49.26 |
Interest & Investment Income | - | - | - | 1.14 | 0.1 |
Currency Exchange Gain (Loss) | - | - | - | 0.32 | -2.45 |
Other Non Operating Income (Expenses) | - | - | - | -0.65 | 1.09 |
EBT Excluding Unusual Items | -15.89 | -13.04 | -126.05 | -8.95 | -113.67 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.57 |
Other Unusual Items | - | - | - | 40.45 | - |
Pretax Income | -15.89 | -13.04 | -126.05 | 31.49 | -113.1 |
Income Tax Expense | - | - | - | 11.36 | 33.23 |
Net Income | -15.89 | -13.04 | -126.05 | 20.14 | -146.33 |
Preferred Dividends & Other Adjustments | - | - | - | - | 0.03 |
Net Income to Common | -15.89 | -13.04 | -126.05 | 20.14 | -146.36 |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 |
Shares Change (YoY) | -0.29% | 0.64% | -0.07% | - | - |
EPS (Basic) | -0.77 | -0.63 | -6.13 | 0.98 | -7.11 |
EPS (Diluted) | -0.77 | -0.63 | -6.13 | 0.98 | -7.11 |
Free Cash Flow | -18.06 | 9.06 | 8.92 | -164.22 | 39.88 |
Free Cash Flow Per Share | -0.88 | 0.44 | 0.43 | -7.98 | 1.94 |
Gross Margin | 94.87% | 100.00% | 27.33% | 38.67% | 21.88% |
Operating Margin | -948.54% | -581.23% | -28.43% | 10.03% | -11.10% |
Profit Margin | -948.54% | -581.23% | -54.85% | 4.46% | -25.73% |
Free Cash Flow Margin | -1078.03% | 403.75% | 3.88% | -36.39% | 7.01% |
EBITDA | -6.96 | -3.97 | -47.46 | 80.82 | 2.15 |
EBITDA Margin | - | -177.00% | -20.65% | 17.91% | 0.38% |
D&A For EBITDA | 8.93 | 9.07 | 17.88 | 35.57 | 65.31 |
EBIT | -15.89 | -13.04 | -65.34 | 45.26 | -63.16 |
EBIT Margin | - | - | -28.43% | 10.03% | -11.10% |
Effective Tax Rate | - | - | - | 36.06% | - |
Revenue as Reported | 1.68 | 2.24 | 239.46 | 459.85 | 573.25 |
Advertising Expenses | - | - | - | 0.45 | 0.51 |